SG11201403306RA - METHOD FOR PRODUCING OPTICALLY-ACTIVE α-SUBSTITUTED-β-AMINO ACID - Google Patents

METHOD FOR PRODUCING OPTICALLY-ACTIVE α-SUBSTITUTED-β-AMINO ACID

Info

Publication number
SG11201403306RA
SG11201403306RA SG11201403306RA SG11201403306RA SG11201403306RA SG 11201403306R A SG11201403306R A SG 11201403306RA SG 11201403306R A SG11201403306R A SG 11201403306RA SG 11201403306R A SG11201403306R A SG 11201403306RA SG 11201403306R A SG11201403306R A SG 11201403306RA
Authority
SG
Singapore
Prior art keywords
group
substituted
amino acid
osaka
active
Prior art date
Application number
SG11201403306RA
Other languages
English (en)
Inventor
Toshihiko Akiyama
Norihiko Hirata
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SG11201403306RA publication Critical patent/SG11201403306RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11201403306RA 2011-12-19 2012-12-06 METHOD FOR PRODUCING OPTICALLY-ACTIVE α-SUBSTITUTED-β-AMINO ACID SG11201403306RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011277194 2011-12-19
PCT/JP2012/082274 WO2013094499A1 (ja) 2011-12-19 2012-12-06 光学活性なα－置換－β－アミノ酸の製造方法

Publications (1)

Publication Number Publication Date
SG11201403306RA true SG11201403306RA (en) 2014-12-30

Family

ID=48668392

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201403306RA SG11201403306RA (en) 2011-12-19 2012-12-06 METHOD FOR PRODUCING OPTICALLY-ACTIVE α-SUBSTITUTED-β-AMINO ACID

Country Status (5)

Country Link
EP (1) EP2796562A4 (ja)
JP (1) JPWO2013094499A1 (ja)
CN (1) CN103998618A (ja)
SG (1) SG11201403306RA (ja)
WO (1) WO2013094499A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106191147B (zh) * 2016-07-08 2020-03-27 凯莱英医药集团（天津）股份有限公司 手性β-氨基酸的制备方法
JP7458680B2 (ja) * 2018-03-30 2024-04-01 株式会社エーピーアイ コーポレーション 新規加水分解酵素及びそれを利用した（１ｓ，２ｓ）－１－アルコキシカルボニル－２－ビニルシクロプロパンカルボン酸の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3704719B2 (ja) * 1993-08-13 2005-10-12 チッソ株式会社 光学活性３−アミノブタン酸の製造法及びそのエステル中間体
JP3875283B2 (ja) 1993-12-15 2007-01-31 住友化学株式会社 エステラーゼ遺伝子
JP3486942B2 (ja) 1994-02-02 2004-01-13 住友化学工業株式会社 耐熱性エステラーゼ
JP4916602B2 (ja) 1998-06-30 2012-04-18 住友化学株式会社 耐熱性エステラーゼおよびその遺伝子
JP2002541197A (ja) 1999-04-09 2002-12-03 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 抗菌剤
CN1435408A (zh) * 2002-02-01 2003-08-13 中国科学院化学研究所 α位有取代基的β－氨基酸的一步加氢合成法
DE10220739A1 (de) * 2002-05-08 2003-11-27 Degussa Verfahren zur enzymatischen Herstellung enantiomerenangereicherter ß-Amionsäuren
EP1745137A1 (en) * 2004-02-27 2007-01-24 DSMIP Assets B.V. Enzymatic preparation of an enantiomerically enriched beta-2-amino acids
JP5157576B2 (ja) * 2007-05-14 2013-03-06 住友化学株式会社 光学活性２−アルキル−１，１，３−トリアルコキシカルボニルプロパンの製造方法

Also Published As

Publication number Publication date
EP2796562A4 (en) 2015-11-25
WO2013094499A1 (ja) 2013-06-27
JPWO2013094499A1 (ja) 2015-04-27
EP2796562A1 (en) 2014-10-29
CN103998618A (zh) 2014-08-20

Similar Documents

Publication Publication Date Title
SG11201408539UA (en) Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
SG11201908062QA (en) Insertion mechanism for drug delivery device
SG11201407117TA (en) Composition for repairing cartilage tissue, method for producing same, and use thereof
SG11201900038QA (en) Compositions and methods comprising improvements of crispr guide rnas using the h1 promoter
SG11201804373VA (en) Compositions and methods for immunooncology
SG11201804738SA (en) Hollow core optical fiber and a laser system
SG11201805838UA (en) Macrocyclic mcl1 inhibitors for treating cancer
SG11201810600WA (en) Fxr (nr1h4) modulating compounds
SG11201804170RA (en) Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
SG11201804934PA (en) Novel Compounds
SG11201408769QA (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
SG11201903287PA (en) Anti-respiratory syncytial virus antibodies, and methods of their generation and use
SG11201808912QA (en) Targeted nucleic acid conjugate compositions
SG11201408157QA (en) Epoxy resin, epoxy resin composition and cured product
SG11201804070XA (en) Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
SG11201407115XA (en) Carboxylic acid compounds
SG11201407851RA (en) Synthesis of pyrrolo [2, 3 - b] pyridines
SG11201408095XA (en) Fibroblast growth factor 21 proteins
SG11201407662WA (en) Process for the preparation of treprostinil and derivatives thereof
SG11201808176TA (en) Gene therapy for treating mucopolysaccharidosis type ii
SG11201804856VA (en) C-terminal lysine conjugated immunoglobulins
SG11201804672QA (en) Systems and methods for production of low oxygen content silicon
SG11201408359PA (en) Novel indanesulfamide derivative
SG11201807540UA (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
SG11201407682TA (en) Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators